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Abstract
Background: Cardiovascular disease (CVD) is the leading cause of death worldwide. Secondary prevention is
essential, but participation rates for cardiac rehabilitation are low. Furthermore, current programmes do not
accomplish that patients with CVD change their lifestyle in a way that their individual risk factors for recurrent
events decrease, therefore more effective interventions are needed. In this study, the effectiveness of the
Hartcoach-programme, a telephonic secondary prevention program focussing on self management, is studied.
Methods/design: A multicenter, randomised parallel-group study is being conducted. Participants are 400 patients
with acute myocardial infarction (STEMI, NSTEMI,) and patients with chronic or unstable angina pectoris (IAP).
Patients are recruited through the participating hospitals and randomly assigned to the experimental group
(Hartcoach-programme plus usual care) or the control group (usual care).
The Hartcoach-programme consists of a period of six months during which the coach contacts the patient every
four to six weeks by telephone. Coaches train patients to take responsibility for the achievement and maintenance
of the defined target levels for their particular individual modifiable risk factors. Target levels and treatment goals
are agreed by the nurse and patient together. Data collection is blinded and occurs at baseline and after 26 weeks
(post-intervention). Primary outcome is change in cardiovascular risk factors (cholesterol, body mass index, waist
circumference, blood pressure, physical activity and diet). Secondary outcomes include chances in glucose, HbA1c,
medication adherence, self-management and quality of life.
Discussion: This study evaluates the effects of the Hartcoach-programme on the reduction of individual risk factors
of patients with CVDs. Patients who are not invited to follow a hospital based rehabilitation programme or patients
who are unable to adhere to such a programme, may be reached by this home based Hartcoach-programme. If
positive results are found, the implementation of the Hartcoach-programme will be extended, having implications
for the management of many people with CVD.
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Background
Although many cardiovascular diseases (CVDs) can be
treated or prevented, an estimated 17.3 million people die
of CVDs each year, representing 30% of all global deaths
[1]. Survivors of a heart attack or stroke are at high risk of
recurrences and at high risk of dying from them as well.
Therefore, secondary prevention is essential. The purpose
of the present study is to evaluate the effects of a home-
based secondary prevention programme focussing on self
management, provided by telephone.
The main controllable risk factors for cardiovascular
disease include elevated cholesterol, high blood pressure,
smoking, overweight, diabetes mellitus and a sedentary
lifestyle [2]. Research has shown that changing these risk
factors to appropriate targets significantly reduces the
risk of recurrent coronary heart diseases, decreases the
need of interventional procedures, and improves quality
of life [3]. However, a treatment gap between scientific
evidence and daily practice exists and current pro-
grammes do not accomplish that patients with coronary
artery disease change their lifestyle in a way that their
individual risk factors for recurrent coronary heart dis-
ease decrease [4-6]. Therefore, more effective lifestyle
management interventions and more proactive manage-
ment of the disease are needed [7].
With a chronic disease such as CVD, the patient
should become a partner in the health care process [8,9].
Complementary to the doctor’s general knowledge, the
patient can provide individual information on his health
status, risk factors, and changes in illness patterns. Since
both sources of information are important for taking ad-
equate treatment decisions, the patient should be ac-
tively involved in his treatment and contribute to almost
every decision. To enhance the ability of patients to ac-
tively participate in their own healthcare and to accom-
plish a central role, guidance in self management is
needed [10]. Adequate self management requires know-
ledge of one’s own individual risk factors, strategies to
influence those factors and the ability to cope with emo-
tions such as fear and frustration [8,9].
Patients with an acute coronary event or unstable an-
gina pectoris are usually admitted to the hospital. In the
Netherlands, the average hospital lengths of stay for
people with coronary diseases diminished between 1995
and 2007 from almost nine days to less than 6 days [11].
One of the impacts of this reduced hospital stay may be
the reduction in time for nurses to offer emotional sup-
port and to provide the patient and his family with pre
discharge education on risk factors and the relation with
lifestyle. People with cardiac disease report dissatisfac-
tion with their education upon discharge and a lack of
professional support [12,13]. Although some patients
participate in a hospital based rehabilitation programme
including life style intervention and self management
after discharge, the availability, content and extensive-
ness of these programmes differ strongly per hospital.
Furthermore, not all patients may be able to visit the
hospital regularly. Therefore, alternative models are
needed to increase access to secondary prevention and
guidance for self management.
In a meta-analysis on different types of secondary pre-
vention programmes for coronary heart disease including
self management strategies, Clark et al. (2010) showed that
home-based interventions compared with usual care sig-
nificantly improved quality of life, systolic blood pressure,
smoking cessation, total cholesterol and depression [14].
Neubeck et al. (2009) concluded from a systematic review
on telehealth interventions including telephone, internet
and videoconference communication, that telephone
based interventions were the most effective in reducing
the patient’s total cholesterol, systolic blood pressure and
low and high lipoprotein [15]. Possibly, a home-based
intervention provided by telephone could help to increase
access to secondary prevention programmes and narrow
the gap between evidence and practice.
A programme that provides home-based education and
professional support for self management after discharge
from the hospital is the COACH-programme (Coaching
Patients On Achieving Cardiovascular Health (COACH).
COACH was developed in Australia [16-18] and is pro-
vided by specifically trained nurses via the telephone. In
this intervention, patients are trained to take responsibility
for the achievement and maintenance of the defined target
levels for their particular individual modifiable risk factors.
In addition, medication adherence is stimulated. Target
levels and treatment goals are agreed upon by the nurse
and patient. Such collaborative goal setting and defining
the targets for treatment is an effective method to pro-
mote self management [19]. The regular telephone con-
tacts not only offer the patient an accessible opportunity
to ask health related questions, but may also provide the
patient with emotional support.
In Australia, the effects of the COACH-programme
have been evaluated. In a randomized clinical trial, the
total cholesterol levels of the group of patients who were
guided according to the COACH-programme were signifi-
cantly lower compared to the cholesterol levels of the
patients who received usual care alone. Furthermore, the
COACH-programme resulted in a greater reduction in
body weight, BMI, dietary intake of total fat, saturated fat,
and anxiety level. Patients who were coached reported bet-
ter health and mood after six months treatment, and
reported more regular walking for exercise [17].
In the Netherlands, Health insurance company Ach-
mea has introduced the COACH concept. Since there
are differences in health care system and cultural back-
ground between both countries, there is a need to repli-
cate the effectiveness study of the Australian programme
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in the Dutch situation. In addition, in the Netherlands,
the coaches providing this intervention are all employed
by Achmea while in Australia coaches were employed by
the hospital. To avoid confusion with another Dutch
programme specifically developed for patients with heart
failure, the COACH-programme is renamed as
“Hartcoach-programme”. The Hartcoach-programme is
expected to have a beneficial effect on reducing risk fac-
tors and health of patients with CVD in the
Netherlands.
Methods
Objectives of this research
Primary aim: To investigate the effect of the Hartcoach-
programme in addition to usual care on the individual
risk factors cholesterol, body mass index, waist circum-
ference, blood pressure, physical activity and diet in
patients with a coronary event (ACS or stable angina
which PCI and / or CABG).
Secondary aim: To see to what extent the Hartcoach-
programme affects glucose, HbA1c, smoking, medica-
tion adherence, self-management, anxiety, depression
and quality of life, compared with usual care alone.
Design
A multicenter, randomised parallel-group study will be
conducted. The experimental group (Hartcoach-
programme plus usual care) will be compared with a
control group (usual care only). Four-hundred patients
diagnosed with CVD in five hospitals will be included,
200 in each group. Patients are recruited through the
participating hospitals and are (in each hospital) ran-
domly assigned to one of the two groups via a compu-
terized procedure at the coordinating research centre
(NIVEL). The Hartcoach study had been approved by
the Medical Ethics Board of the University of Amster-
dam, The Netherlands.
Participants
Participants are patients aged between 18 and 80 years
with documented evidence of coronary heart disease
who have been hospitalized less than 8 weeks before in-
clusion. This includes patients with an acute myocardial
infarction (STEMI, NSTEMI,) and patients with chronic
or unstable angina pectoris (IAP). Patients may have
been treated with revascularization procedures, either
coronary artery bypass graft surgery (CABG) or percu-
taneous coronary intervention (PCI) and/or with medi-
cation. Exclusion criteria are:
– planned surgery, percutaneous coronary
intervention or other interventions;
– limited life-expectancy (< 2 years) according to the
treating cardiologist;
– NYHA class III or IV heart failure;
– previous or current similar life style interventions
(i.e. any intervention with multiple sessions
focussing explicitly or exclusively on changing
patients life style; cardiac rehabilitation in which
occasionally advices according to life style are
given is allowed);
– no telephone;
– insufficient control of the Dutch language.
Recruitment
All patients of the participating hospitals who meet the
inclusion criteria are informed about the study by a spe-
cifically trained research assistant of the hospital. The
patient informed consent information letter contains in-
formation about the nature of the study, the randomisa-
tion procedure and data collection at baseline and post
test after 6 months. Treating specialists are instructed
that the study will take place in their medical centre and
are informed about the objective of the study. The
patient’s general practitioner will be informed about the
participation of their patient.
Study setting
The study concerns a home based secondary interven-
tion programme provided per telephone. Patients are
recruited from the Departments of Cardiology of sev-
eral Medical centres in the Netherlands. All measure-
ments (body length, weight, waist circumference, blood
pressure, anamnesis and patients questionnaire) are
performed by research nurses in these hospitals. Blood
values are determined in the hospitals laboratory.
Intervention
The Hartcoach-programme consists of a period of
6 months in which the coach contacts the patient
every four to six weeks by telephone. The Dutch coa-
ches are nurses who are working at the medical call
centre of Achmea in Zwolle. They were trained in the
spring of 2009 in Australia and additionally partici-
pated in a course on Motivational Interviewing in
2011.
Before starting the first coaching session, the baseline
values for risk factors and medication use are established.
In each contact, a continuous quality improvement
cycle is followed [17]:
1. Education – part 1. Asking questions to establish
patients’ knowledge, attitude and beliefs about their
risk factors. Questions are asked about medication,
physical activity and dietary intake of saturated fat.
2. Education – part 2. The patient is informed and
educated about those aspects for which his/her
knowledge is insufficient.
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3. Assertiveness training / empowerment. The patient
is trained to be assertive in his/her relation with the
doctor: to obtain the cholesterol level, to agree upon
the target cholesterol level, to alter medication or
doses if appropriate etc.
4. Goal setting. Negotiating of a plan of action and
setting goals to be achieved by the next coaching
session.
5. Reassessment at the next coaching session. Patient
adherence to the negotiated plan of action is
evaluated.
The coaches register per telephone call the date, topics
that were discussed, advices given and agreements made.
The patient receives a written letter with the most im-
portant advices and appointments summarized. Based
on these reports, the researchers are able to verify
whether the intervention is performed as intended. In
daily practice, the coaching cycle is continued until tar-
get levels for risk factors are reached, usually in about
6 months. For the purpose of this study, the coaching
cycle is set to 6 months exactly, in order to achieve simi-
lar post-treatment periods for all patients.
The experimental group will receive the Hartcoach-
programme in addition to the usual care patients receive
after they are discharged from the hospital. Usual care in
the Netherlands differs per hospital and per patient, and
can consist of visiting the cardiologist, general practi-
tioner, physical therapist, dietician and/or taking medica-
tion. Usual care may also include cardiac rehabilitation.
In case this rehabilitation mainly and specifically focuses
on life style modification, the patient is excluded from
the study. The control group receives usual care only. In
a dairy, all patients register the amount and type of usual
care they receive. In this way, insight is given in the
usual care patients actually received and in case the
amount and type of usual care differs between both
groups, there will be controlled for it in the data
analyses”.
After the post measurement after 6 months, patients
from the control group are offered to participate in the
Hartcoach-programme.
Outcomes
All measurements for both the experimental- and the
control group are performed at baseline after receiving
the informed consent (T0) and before starting the
Hartcoach-programme, and after 6 months (T1)
a. Defini-
tions of primary and secondary outcome measures are
presented in Table 1. Targets presented in this table re-
flect the ideal outcomes. However, in the coaching ses-
sions individualized and feasible targets are defined that
may not always fully correspond with those ideal
outcomes. For example, a patient may strive for less
smoking instead of fully quit smoking.
In addition to the outcome measures, also gender,
educational status, civil status, work status, the occur-
rence of life events in the past 12 months, ethnicity, car-
diovascular history, treatment history, medication use
and co morbidity are registered by the research assistant
or nurse at baseline. Data are filled in using an electronic
questionnaire.
Through a self developed (paper) patient questionnaire
smoking, alcohol consumption, self care strategies in re-
lation to coronary diseases and illness perception are
measured. At six months, all measurements are
repeated, except measurements of demographic charac-
teristics. In addition, usual care received during the six
months is registered through a patient dairy, and
patients are asked about their experiences with the
Hartcoach-programme.
Randomisation and blinding
After informed consent has been obtained, each patient
is randomly assigned to one of the two groups, regard-
less the medical centre the patient is treated. After the
nurse has logged on to a specific portal, the patient is
allocated computerized using a PHP RAND function to
“Hartcoach + usual care” (experimental group) or to
“usual care” alone (control group). The coordinating re-
search centre informs the patient about the randomisa-
tion by a written letter. The measurements are
performed by research-assistants or nurses in the treat-
ing hospital, who are blinded to allocation.
Sample size calculation
Sample size calculation was based on one of the primary
outcomes that were also used in the study of Vale et al
(2003), namely total cholesterol. Based on the values
found by Vale et al (2003) for total cholesterol (between
groups difference of 0.36 mmol / L (95% confidence inter-
val: 0.20-0.53 mmol / L) 160 patients per group would be
needed to find statistical significant results (power of 0.80
and alpha of 0.05)[17]. In this study, a sample of 200
patients per group is chosen, to account for dropout.
Statistical analysis
Data will be analyzed according to the intention-to-treat
principle [25]. All patients, irrespective of completion of
the Hartcoach-programme, will be included in the ana-
lysis. To determine the effect of the Hartcoach-
programme, multilevel analysis will be used because the
data have an intrinsic hierarchical nature. Patients are
"nested" in hospitals and data are therefore not inde-
pendent, violating a major assumption of traditional stat-
istical procedures. The model we will use is a multilevel
mixed model for repeated measures, a method in which
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all available data are adequately used: both the paired
observations of patients who completed the intervention,
as the details of the people who did not complete the
Hartcoach-study [26].
Bivariate and multivariate analyses will be used to as-
sess the effects of the intervention (compared to con-
trols) on the individual risk factors cholesterol, body
mass index, waist circumference, blood pressure, phys-
ical activity, diet, glucose, HbA1c and smoking, as well
as on medication adherence, self-management, anxiety,
depression and quality of life. The mean change in risk
factors between 0 and 6 months is compared between
intervention and control group. Age, gender, ethnicity,
educational status, civil status, work status, the occur-
rence of life events in the past 12 months, cardiovascular
history, medication use and co morbidity will be
included as possible covariates. Data will be analyzed
with the statistical packages Stata and MLWIN.
Discussion
In this study, the effect of an evidence based telephone
coaching programme (Hartcoach) in addition to usual
care is evaluated on the reduction of individual risk fac-
tors of patients with CVD. Current programmes do not
accomplish that patients with CVD change their lifestyle
in a way that their individual risk factors for recurrent
coronary events decrease. Hospital based rehabilitation
programmes in the Netherlands differ strongly per hos-
pital, both in content and extent. Furthermore, participa-
tion rates are rather low. The Hartcoach-programme is a
pragmatic intervention that primes the patient to self
management by adhering to medication and make rele-
vant behaviour changes. Today’s policy is to enhance self
management of patients as a means of improving long-
term conditions and secondary prevention.
Patients who are not given the opportunity to follow a
rehabilitation programme in the hospital or patients who
are not able or motivated to adhere to a hospital based re-
habilitation programme, may be reached by a home based
programme. Another potential benefit of the Hartcoach-
programme may be the positive influence the programme
can have on medication adherence. In the Netherlands,
statins are prescribed to almost every patient after an
acute coronary event, but medication adherence to statins
Table 1 Study outcomes, targets and measurements at T0 and T1
Primary outcomes Target Measurement
BMI ≤25; or at least 5% reduction
of bodyweight
Height: measured without shoes, by nurse Weight:
measured without coat and shoes, by nurse
Waist circumference ♀≤ 88 cm, ♂≤ 102 cm Measured by nurse with a measuring tape halfway
between the lowest rib and the top of the hipbone
around the abdomen, under (or without) clothing.




< 140 mmHg Measured by nurse with an automatic sphygmomanometer.
Patient is seated and both arms are measured. Measurement
on the arm with the highest systolic blood pressure is repeated.
The mean value of these both measurements is registered
Total cholesterol ≤ 5,0 mmol/l Laboratory*
LDL cholesterol ≤ 2,5 mmol/l Laboratory
HDL cholesterol ≥ 1,0 mmol/l Laboratory
Diet 2 ounces of vegetables,
2 pieces of fruit,
20–35% energy intake of fat;




Blood glucose fasting glucose< 7 mmol/l Laboratory
HbA1c (%) < 53 mmol/mol (< 7%) Laboratory
Smoking fully quit Patient questionnaire: Self report, one question
Self management Patient questionnaire: Self report, five questions
Medication adherence Full adherence Patient questionnaire: Adapted Morisky Scale [22]
Quality of life Patient questionnaire: MacNew Heart Disease
Health-related Quality of Life Questionnaire [23]
Depression Anxiety Patient questionnaire: Hospital Anxiety
and Depression Scale (HADS; [24])
* blood values are analysed by the laboratory in the medical centre the patient is treated, according to local standard practice.
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is known to be low. One-year persistence with statins has
been estimated to be about 60% in patients with previous
cardiovascular events [27-29].
A limitation of the study is the reliance on self report
according to two of the primary outcomes, physical ac-
tivity and diet. Since patients are not blinded to group
allocation, this might have an impact on the results.
However, both measurements, especially diet, are diffi-
cult and laborious to administer in a more reliable and
valid manner. Another methodological weakness of the
study is the fact that all patients receive usual care next
to the Hartcoach-programme and some of the partici-
pant may follow a rather intensive rehabilitation
programme. Additional effects of the Hartcoach-
programme next to intensive rehabilitation may be too
small to detect. However, in the Netherlands the
Hartcoach-programme is implemented as an additional
programme and was never intended to substitute usual
care. Thereby, the amount of usual care and contingent
cardiac rehabilitation is registered and can be taken into
the analyses, while it is expected that there will also be a
large number of patients who receive minimal care and
support in managing their individual risk factors besides
the Hartcoach-programme.
A large Dutch health insurance company (Achmea)
already has introduced this programme to a limited
number of hospitals and the Hartcoach-programme is
offered to their clients. If positive results are found for
the Hartcoach-programme, the implementation of the
programme will be extended which will have implica-
tions for the management of many people with CVD.
The Hartcoach-programme can be provided additional
to existing services or as a "maintenance" programme for
people after cardiac rehabilitation.
Endnotes
a During the study, we will try to find additional fund-
ing for a measurement at 12 months. This would not
only provide a follow-up measurement but will also
change the study design as the control group is invited
to follow the Hartcoach-programme after completion of
the six months measurement.
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